Viewing data from:

ISOSORBIDE MONONITRATE

ANDA

ISOSORBIDE MONONITRATE | A216557 | AUROBINDO PHARMA LTD

3 strengths0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 5 NDCs

Highest NADAC/Unit

$0.1656

per ea

Lowest NADAC/Unit

$0.0751

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
59651054101ISOSORBIDE MONONIT ER 120 MG	$0.1656	EA	Generic	—	2026-06-17
59651054001ISOSORBIDE MONONIT ER 60 MG TB	$0.0952	EA	Generic	—	2026-06-17
59651054005ISOSORBIDE MONONIT ER 60 MG TB	$0.0952	EA	Generic	—	2026-06-17
59651053901ISOSORBIDE MONONIT ER 30 MG TB	$0.0751	EA	Generic	—	2026-06-17
59651053905ISOSORBIDE MONONIT ER 30 MG TB	$0.0751	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain0 active DMFs1 inactive

0 active API suppliers hold Drug Master Files for this ingredient. Limited supplier base — potential supply chain risk.

SHANDONG NEW TIME PHARMACEUTICAL CO LTDInactiveISOSORBIDE MONONITRATE (NON-STERILE, BULK FORM)

DMF 208162007

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (3)

Sort:

#001 — 30MG

0 patents0 exclusivities▴

TABLET, EXTENDED RELEASE;ORAL | Approved: Nov 7, 2022

No patent or exclusivity listings for this strength.

#002 — 60MG

0 patents0 exclusivities▾

TABLET, EXTENDED RELEASE;ORAL | Approved: Nov 7, 2022

#003 — 120MG

0 patents0 exclusivities▾

TABLET, EXTENDED RELEASE;ORAL | Approved: Nov 7, 2022